Overview of opportunities and challenges associated with next generation sequencing (NGS) and genomic medicine
More comprehensive at reduced cost
Informatic burden of data processing and storage
Mendelian diseases such as LQT and HCM
Diagnosis of sporadic cases with genetic disease
Molecular autopsy following sudden death
Prenatal diagnosis
Discriminating disease causing variants from rare benign variants
Treatment targeted to a molecular defect
Treatment stratification by genotype
Predicting drug response
Data protection
Unexpected findings such as non-paternity or a genetic abnormality unrelated to presentation
Inclusion of genomic medicine in training curricula
HCM, hypertrophic cardiomyopathy; LQT, long QT syndrome.